Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arris to acquire Khepri in $20-$22 mil. deal; hopes to lower burn rate 25%.

Executive Summary

ARRIS TO ACQUIRE KHEPRI FOR $20-$22 MIL., Arris Corp. announced Nov. 8 after signing a definitive agreement with Khepri Pharmaceuticals. The signing culminates talks initiated by Arris in the summer of 1994. Arris will issue 1.5 mil. shares of stock to Khepri shareholders in December, when the acquisition is expected to have its first-stage closing. At that time, the issued shares will be subject to contractual lock-up: approximately 1 mil. shares may not be sold to the public until Jan. 1, 1997. In the second stage of the closing, an additional 525,000 shares or their cash equivalent will be issued on Dec. 30, 1996.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel